The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
FDA approves Wegovy to lower risk for CVD events in patients with obesity
Mar 08, 2024
Agency’s action could widen access to the drug if more insurance companies decide to cover it
American Stroke Association, Feb. 7-9
Feb 20, 2024
The conference featured presentations that emphasized basic, clinical and translational medicine and provided insight into the prevention, management and treatment of stroke.
AI-aided system can help improve stroke rehab, reduce risk of second emergency, report finds
By
Aaron Dorman
Feb 12, 2024
A new AI model was able to reduce older adults’ recurrent strokes, heart attacks and vascular death, researchers discovered.
Seniors, caregivers, have new and easier methods to monitor heart health — 5 innovations
By
Aaron Dorman
Feb 07, 2024
Five new tools for heart health range from new implantable devices to novel tests that provide a view of one’s risk for an emergency.
Clinicians and caregivers must keep pace with new pacemaker tech available for seniors: study
By
Aaron Dorman
Feb 06, 2024
A new survey classifies cardiac implantable electronic devices, or CIEDs, to account for advances such as leadless multi-chamber pacemaker models.
Defibrillator drones beat ambulances to the scene of cardiac arrest, new research shows
By
Aaron Dorman
Nov 28, 2023
Drones could offer emergency relief to heart attack sufferers faster than a traditional ambulance, a new study reveals.
This long-term care provider keeps the lights on without throwing sleep cycles off
By
Aaron Dorman
Nov 10, 2023
Special lighting systems can help maintain seniors’ circadian rhythms and sleep cycles, one LTC operator says.
Million hearts model cuts five-year heart attack, stroke risk in at-risk patients
Oct 18, 2023
Improved outcomes were seen, with no significant changes in Medicare spending.
ESC: Adverse outcomes increased with suboptimal adherence to aspirin after MI
Aug 28, 2023
The risk increased for recurrent MI, ischemic stroke or death with suboptimal adherence through eight years after MI.